Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioDelivery Sciences Inte...

    NASDAQ: BDSI · Real-Time Price · USD
    5.59
    -0.00 (-0.09%)
    At close: Mar 22, 2022, 9:00 PM

    BioDelivery Sciences International Statistics

    Share Statistics

    BioDelivery Sciences International has 103.23M shares outstanding. The number of shares has increased by 4.74% in one year.

    Shares Outstanding

    n/a
    		 103.23M

    Shares Change (YoY)

    n/a
    		 4.74%

    Shares Change (QoQ)

    n/a
    		 4.49%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 86.76M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.6M, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.6M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1.77

    Valuation Ratios

    The PE ratio is 3.77 and the forward PE ratio is null. BioDelivery Sciences International's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 3.77

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.92

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.7

    P/FCF Ratio

    n/a
    		 7.88

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    BioDelivery Sciences International has an Enterprise Value (EV) of 264.69M.

    EV / Sales

    n/a
    		 1.59

    EV / EBITDA

    n/a
    		 5.94

    EV / EBIT

    n/a
    		 6.45

    EV / FCF

    n/a
    		 6.52

    Financial Position

    The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.31.

    Current Ratio

    n/a
    		 2.45

    Quick Ratio

    n/a
    		 2.17

    Debt / Equity

    n/a
    		 0.31

    Debt / EBITDA

    n/a
    		 1.32

    Debt / FCF

    n/a
    		 1.45

    Interest Coverage

    n/a
    		 4.95

    Financial Efficiency

    Return on Equity is 45.18% and Return on Invested Capital is 43.09%.

    Return on Equity

    n/a
    		 45.18%

    Return on Assets

    n/a
    		 26.14%

    Return on Invested Capital

    n/a
    		 43.09%

    Revenue Per Employee

    n/a
    		 $833,515

    Profits Per Employee

    n/a
    		 $424,300

    Employee Count

    n/a
    		 200

    Asset Turnover

    n/a
    		 0.51

    Inventory Turnover

    n/a
    		 0.99

    Taxes

    Income Tax

    n/a
    		 -55.24M

    Effective Tax Rate

    n/a
    		 -186.48%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0, so BioDelivery Sciences International's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 4.91

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 84

    Average Volume (20 Days)

    n/a
    		 3,352,473

    Income Statement

    In the last 12 months, BioDelivery Sciences International had revenue of 166.7M and earned 84.86M in profits. Earnings per share was 0.82.

    Revenue

    n/a
    		 166.7M

    Gross Profit

    n/a
    		 143.33M

    Operating Income

    n/a
    		 37.12M

    Net Income

    n/a
    		 84.86M

    EBITDA

    n/a
    		 44.54M

    EBIT

    n/a
    		 37.12M

    Earnings Per Share (EPS)

    n/a
    		 0.82
    Full Income Statement

    Balance Sheet

    The company has 114.31M in cash and 58.79M in debt, giving a net cash position of 55.52M.

    Cash & Cash Equivalents

    n/a
    		 114.31M

    Total Debt

    n/a
    		 58.79M

    Net Cash

    n/a
    		 55.52M

    Retained Earnings

    n/a
    		 -256.02M

    Total Assets

    n/a
    		 324.6M

    Working Capital

    n/a
    		 119.69M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 41.04M and capital expenditures -415K, giving a free cash flow of 40.62M.

    Operating Cash Flow

    n/a
    		 41.04M

    Capital Expenditures

    n/a
    		 -415K

    Free Cash Flow

    n/a
    		 40.62M

    FCF Per Share

    n/a
    		 0.39
    Full Cash Flow Statement

    Margins

    Gross margin is 85.98%, with operating and profit margins of 22.27% and 50.9%.

    Gross Margin

    n/a
    		 85.98%

    Operating Margin

    n/a
    		 22.27%

    Pretax Margin

    n/a
    		 17.77%

    Profit Margin

    n/a
    		 50.9%

    EBITDA Margin

    n/a
    		 26.72%

    EBIT Margin

    n/a
    		 22.27%

    FCF Margin

    n/a
    		 24.37%

    Dividends & Yields

    BDSI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 26.5%

    FCF Yield

    n/a
    		 12.69%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BDSI.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $20.5

    Lynch Upside

    n/a
    		 266.73%

    Graham Number

    n/a
    		 5.8

    Graham Upside

    n/a
    		 3.76%

    Scores

    Altman Z-Score

    n/a
    		 2.72

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist